Last reviewed · How we verify
NCT05026775: IMA-cRCT
Effectiveness and Cost-effectiveness of the Initial Medication Adherence Intervention
Status unknown
NA
Last updated 12 October 2022
What this trial tests
NA trial testing Initial Medication Adherence (IMA) in Adherence, Medication in 4,153 participants. Status unknown.
Timeline
1 March 2022
Primary endpoint
30 September 2022
30 September 2022
30 September 2023
Quick facts
| Lead sponsor | Fundació Sant Joan de Déu |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 4,153 |
| Start date | 1 March 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2023 |
| Sites | 24 locations across Spain |
Drugs / interventions tested
- Initial Medication Adherence (IMA)
- Usual care
Conditions studied
- Adherence, Medication — all drugs for Adherence, Medication →
Sponsor
Fundació Sant Joan de Déu — full company profile →
Who can join
18 and older, any sex, with Adherence, Medication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the effectiveness and the cost-effectiveness of the Initial Medication Adherence (IMA) Intervention.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study).
Sánchez-Viñas A, Corral-Partearroyo C, Gil-Girbau M, Peñarrubia-María MT, et al · · 2022 · cited 11× · PMID 35790915 · DOI 10.1186/s12875-022-01727-6 -
Complex multidisciplinary intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): mixed-methods process evaluation protocol.
Corral-Partearroyo C, Sánchez-Viñas A, Gil-Girbau M, Peñarrubia-María MT, et al · · 2022 · cited 5× · PMID 36316078 · DOI 10.1136/bmjopen-2022-067468 -
Effectiveness of a patient-centred complex intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): a pragmatic cluster randomised controlled trial using real-world data.
Corral-Partearroyo C, Sánchez-Viñas A, Aznar-Lou I, Peñarrubia-María MT, et al · · 2025 · cited 2× · PMID 40592577 · DOI 10.1136/bmjqs-2024-018402 -
Implementation of a patient-centred complex intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study): a mixed-methods process evaluation.
Corral-Partearroyo C, Sánchez-Viñas A, Peñarrubia-María MT, Gil-Girbau M, et al · · 2025 · cited 2× · PMID 40484629 · DOI 10.1136/bmjqs-2024-018403 -
Cost-effectiveness of a shared decision-making intervention for patients receiving treatments for cardiovascular disease and diabetes in primary care: a cluster randomised controlled trial based on real-world data (IMA-cRCT study)
Rubio-Valera M, Sánchez-Viñas A, Corral-Partearroyo C, Peñarrubia-María MT, et al · · 2025 · DOI 10.21203/rs.3.rs-8348455/v1
Verify or expand the search:
- PubMed search for NCT05026775
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adherence, Medication
Currently open trials in the same condition.
- NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting
- NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
- NCT06056037 — Making ART Work Among Brazilian Youth · NA · recruiting
- NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction · active not recruiting
- NCT05374109 — SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth · NA · active not recruiting
Other Fundació Sant Joan de Déu trials
Trials by the same sponsor.
- NCT07508917 — Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation · Phase 1, PHASE2 · not yet recruiting
- NCT06556251 — Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme · NA · recruiting
- NCT06309121 — Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents · NA · active not recruiting
- NCT07091344 — Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis · NA · recruiting
- NCT06340555 — Intervention to Prevent Mental Health Disorders of Women and Their Partners Who Experienced Pregnancy Loss · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT05026775 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació Sant Joan de Déu
- Last refreshed: 12 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05026775.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing